Veterinary drugs are used as therapeutic, prophylactic and growth promotion, and can be used in either rational or irrational way. Rational use of drugs means the sick animals receive medications appropriate to their clinical needs, in doses that meet their own individual requirements, for an adequate period of time, and at the lowest cost to them and their community. Irrational drug uses are characterized by over-prescription, inappropriate dosage, incorrect duration and unnecessary risk. There are several reasons which may contribute to irrational use of drugs. Some of them are lack of information, inadequate training and education of graduates of veterinary medicine, poor communication between veterinarian and owner, lack of diagnostic facilities, demand from the animal owner, and promotional activities of pharmaceutical industries. Hence, the potential public health hazard as a result of irrational drug use in food animals includes limited efficacy, increase risk of unwanted effects such as the emergence of drug resistance and drug residue, waste of resources and psychosocial impacts. However; rational use of drugs in veterinary medicine has manifold significance; it can be either public health significance, improve food safety concern, reduce the development of drug resistance and residue or economic significance; the need to rely on more expensive drugs and international trade barrier. Some of the measures that promote rational drug use are: herd health management, alternatives for antimicrobials growth promoters, adhering to withdrawal period and minimizing misuse of antimicrobials.
Key words: Rational/irrational use, veterinary drugs, drug residue, and resistanceAbbreviation: E. coli, Escherichia coli; FAO, Food and Agriculture Organization; GIT, gastro-intestinal tract; GP, growth promoter; IDU, irrational drug use; JECFA, Joint FAO/WHO Expert Committee on Food Additives; MRL, maximum residue level; NAS, National Academic Sciences; OIE, Office International des Epizooties; RDU, Rational drug Use; Vet, veterinary; Vet. Med, veterinary medicine; WHO, World Health Organization; WP, withdrawal period.
Drugs in animals can be used for various purposes, such as therapeutic, prophylactic (Hirsh and Zee, 1999), growth promotion and other uses (Kanneene and Miller, 1997). When veterinary drugs are indicated rationally in right dose and route of administration, the potential damages of their use are reduced and their efficacy increased (Vitomir et al., 2011). Rational use of drugs in veterinary medicine has both public health (FAO/OIE/WHO, 2003) and economic significances (World Health Organization(WHO), 2001).Non-rational use of drugs in veterinary medicine, as well as the need for control of their use becomes even bigger problem when used on food producing animals (Vitomir et al., 2011). The irrational antimicrobials use causes a particular concern for unwanted residues in foods of animal origin and for the development of antimicrobial resistance (Catery et al., 2003). To maintain the efficacy of antibiotics and use them for long lasting and to reduce the risk of resistant bacteria development, the use of antibiotics must be restricted (WHO, 2001).
Maintaining all food animals in a clean healthy environment and developing a nutritional program to meet growth, maintenance and lactation needs of animals are crucial. Hence, drug misuse is best avoided by implementing management practices and health programs that keeps animals healthy and producing efficiently (American Veterinary Medical Association (AVMA) and National Milk Producers Federation (NMPF), 1999; Radostitis, 1994). Therefore, this review provides an overview on importance of rational veterinary drug use in food safety, its public health and economic significances, and the control measures of irrational veterinary drug use in food of animal origin.
USES OF VETERINARY DRUGS
Drugs in animals can be used as in therapeutic, prophylactic and growth promotion. Therapeutic use refers to the treatment of established infections whereas prophylaxis is the use of drugs in either individual or groups to prevent the development of infections. Both therapeutic and prophylactic uses involve administrations of drugs by different routes at therapeutic levels for short period of time (Hirsh and Zee, 1999). The use of antimicrobials as feed supplements can promote the growth of food animals and also enhance feed efficiency (Graham et al., 2007; NAS, 1999; Kanneene and Miller, 1997).
Therapeutic and prophylactic
Most drugs, around 60%, are used for therapeutic purposes in humans, although an increasing amount is administered as prophylaxis to prevent infection, the farming industry is the second largest consumers of antimicrobials after medical practitioner. Depending on action, prophylactic and therapeutic drugs may be divided into different groups. The most widely distributed drugs are antimicrobials, antiparasitic and antimycotic prepara-tions and their use in prevention and treatment of animal diseases (WHO, 2001). Veterinary drug products licensed for use throughout the world do not vary greatly from country to country, although the level of use, with-drawal times accepted safe level in food do change from country to country in almost all cases. Depending on the requirements in different countries, feedstuffs containing veterinary drugs may be available only on the pres-cription of a veterinarian or they may be freely available. In most circumstances, if recommended withdrawal periods are observed, the presence of unacceptable residues is not expected (Fingleton, 2004).
The choice of antimicrobial drugs to use for the treat-ment of animal diseases caused by an infectious agent should be in line with the guidelines as it aids in decision making process. The gold standard for this determination is the result of microbiological culture. However, strict application of this standard is unrealistic because the decision to use antimicrobial drugs is made several days before culture data are available. Therefore, as an aid in determining that a particular process has infectious com-ponent, certain clues are used. The Infectious Control Committee at Veterinary Medical Teaching Hospital, University of California has drawn up guidelines for rational use of antimicrobial drugs which are: demonstra-tions of an infectious agent; clinical data (at least two of the following): fever; leukocytosis; localized inflammation and radiographic evidence. The whole purpose of the exercise is to know whether there is an infectious agent present or the best antimicrobial drugs to be used (Hirsh and Zee, 1999).
“Growth promoters’’ are any antimicrobial agents administered at low or subtherapeutic dose and destroys or inhibits growth of microbes as infectious agents reduce the yields of food animals (Peter and John, 2001). Antibiotic GPs are used to help growing animals by increasing the rate of weight gain and to improve feed conversion efficiency (Graham et al., 2007; Jensen, 1998), and get maximum benefit from it and allow them to develop into strong and healthy individual.
Although the mechanism underlining their action is unclear, it is believed that the antibiotic suppresses sensitive populations of bacteria in the intestines. It has been estimated that as much as 6% of the net energy in the pig diet could be lost due to microbial fermentation in the intestine. If the microbial population could be con-trolled, it is possible that the lost energy could be diverted to growth (Jensen, 1998). It is also hypothesized that cytokines released during immune response as a result of bacterial infection may stimulate the response of cata-bolic hormones, which could reduce muscle mass. There-fore, a reduction in gastro intestinal tract (GIT) infections would result in the subsequent increase in muscle weight.
Whatever the mechanism of action, the result of the use of GPs are resulting in meat of better quality, with less fat and increased protein content (Peter and John, 2001). There can be no doubt that GPs are effective; however, the effects of GPs are more noticeable in sick animals and those housed and confined, and unhygienic conditions (Prescott and Baggot, 1993). The use of GP is largely a problem of intensive farming methods and the problems caused by their use are largely those of developed rather than developing countries (Peter and John, 2001).
OTHER USES OF VETERINARY DRUGS
In preservation and processing, food additives are added to prevent the onset of spoilage, to promote the binding properties and to enhance flavor and nutritive value. These additives include antioxidants, sequestrants, coloring agents, stabilizers, sweeteners, tenderizers, etc. At both production and processing stages, residues or contaminants may enter the food chain from intentional exposure to these chemicals (Gracey et al., 1999).
Certain neuroleptic drugs (tranquilizers) are administered to avoid excitement of animal or to curb aggressive behavior. The misuse of such drugs and some beta-adrenergic blocking are used to reduce the stress of transportations to the slaughter house raises concern from the view point of consumer protection. Residues of drugs given for these purpose will remain at a high level in edible tissues, since animals are slaughtered shortly after the drug is administered and while the concentration of the drug remains at therapeutically effective levels (FAO, 1984).
Control of reproduction
Prostaglandins and their analogs and sex steroids are used to regulate fertility and breeding programmes. Glucocorticoids and prostaglandins are used as abortifacients or to control timing of parturition. Animals would not be slaughtered shortly after the treatment and residue problem in meat could only occur in the event of causality meat slaughter (FAO, 1984).
WAYS OF VETERINARY DRUG USE
Rational veterinary drug use
Rational use of medicines in veterinary science is defined as that sick animal should receive medications appro-priate to their clinical needs, in doses that meet their own individual requirements, for an adequate period of time, and at the lowest cost to them (WHO, 2002). These requirements will be fulfilled if the process of prescribing is appropriately followed. This includes: steps in defining patients’ problems (or diagnosis); in defining effective and safe treatments (drugs and non-drugs); in selecting appropriate drugs, dosage and duration; in writing a prescription; in giving patients adequate information; in planning to evaluate treatment responses (WHO, 1988).
Irrational veterinary drug use
Irrational drug use or inappropriate drug uses are characterized by over-prescription (prescribing drug when none are needed clinically), omission (when required drugs for conditions are not prescribed), the use of inappropriate dosage (too high or too low), incorrect duration (too short or too long), incorrect selection (mismatch between organism) and unnecessary risk (use of injection or intravenous antibiotic when oral forms would be suitable) (Brahma et al., 2012). The irrational drug use causes a particular concern for the development of resistance. Antimicrobial drug is now becoming a major problem both in veterinary and human medicine as consequence of the intensive use and misuse of antimicrobial drugs (Catery et al., 2003). There is a wide spread misuse of permitted drugs which result in unwanted residues in foods of animal origin. Also, there has been wide spread failure to observe the recommended withdrawal and withholding period for antimicrobial agents (Thawani, 2010).
REASON FOR IRRATIONAL USE OF DRUGS
There are several reasons which may contribute to irrational use of drugs. These are: lack of information; faulty and inadequate training and education of medica and/or veterinary graduates; poor communication between health professional and animal owner; lack of diagnostic facilities/uncertainty of diagnosis; demand from the owner (to satisfy the patient expectations and demand of quick relief, clinicians prescribe drugs for every single complaint). Also, there is a belief that “every ill has a pill”. All these increase the tendency of poly-pharmacy, defective drug supply system and ineffective drug regulation (absence of well-organized drug regulatory authority and presence of large numbers of drugs in the market leads to irrational use of drugs) and promotional activities of pharmaceutical industries (the lucrative promotional programmes of the various pharmaceutical industries influence the drug prescribing) (Brahma et al., 2012; Shivhare et al., 2010).
IMPACTS OF IRRATIONAL USE OF DRUGS
Irrational use of drugs can have a negative impact on the public health, some of them are as follows: reduction in the quality of drug therapy (limited efficacy) leading to increased morbidity and mortality; increase risk of unwanted effects such as adverse drug reactions and the emergence of drug resistance due to widespread overuse of antibiotics as well as their use in under-therapeutic dosage; waste of resources leads to reduced availability of other vital drugs and increased costs and adverse, possibly lethal effects, for example due to antibiotic misuse or inappropriate use of drugs in self-medication (Brahma et al., 2012); psychosocial impact, such as when patients come to believe that there is "a pill for every ill", which may cause an apparent increased demand for drugs (Grandle et al., 1993).
SIGNIFICANCE OF RATIONAL VETERINARY DRUG USE
Rational use of drugs in veterinary medicine has public health and economic significances.
Public health significance
No significant reported episodes of adverse human health effects occurring in food when the veterinary drugs were used at the correct dosages and at the levels permitted (FAO/OIE/WHO, 2003).
Improve food safety concern
When drugs indicated rationally, the potential adverse effects of their use as a result of consumption of animal products. However, in non-rational use of drugs in veterinary medicine, mainly when used on food producing animals, there is the possibility that minimal quantities of drugs and their metabolites (residues) which remain in animal products (meat, milk, eggs and honey) and induce certain harmful effects in people as potential consumers of such food (Vitomir et al., 2011).
Reduce the development drug resistance
Human health can be affected by a widespread of antibiotic resistance pathogens, as it is occurring due to extensive overuse of antibiotics, as well as their use in under-therapeutic dosage (Brahma et al., 2012). Resistant microorganism can get access to human either through direct contact or indirectly via meat, milk, egg. As the bacteria, the endogenous flora of food animal, contaminate food of animal origin, might either colonize human or transfer resistant gene to humans endogenous flora or super impose an additional load to the reservoir of resistant genes already present in man (Stobberingh and Bogaard, 2000).
The use of antibiotics in food animal can result in anti-biotic resistance bacteria reaching the human population through variety of routes. Antimicrobial resistant bacteria such as Escherichia coli can colonize intestines of heavily exposed humans (farmers, who used food containing antibiotics, slaughter house workers, cookers and other food handlers) often have a higher in-cidence of resistant E.coli in their feces than the general population. Contaminated meat by intestinal bacteria at slaughter is extensive and an important route by which resistant bacteria reach people. While many bacteria are non-pathogenic, some pathogenic bacterial species from the intestines of animals causes zoonotic infection to humans such as Salmonella species, Campylobacter jejuni and these infection may be harder to treat because it is acquired by humans and are a potential source of resistance plasmids for human pathogenic bacteria other than zoonotic infection (Hirsh and Zee, 1999). Rational use of drugs can also signifi-cantly minimize the risk of microorganisms resistance development (in case of antimicrobials). Hence, no significant reported episodes of adverse human health effects occurring in food when the veterinary drugs were used at the correct dosages and at the levels (FAO/OIE/WHO, 2003).
Reduce the development of drug residue
Veterinary drug residues are one of the major problems for food contamination. Human health can be affected through residues of drugs in food of animal origin, which may cause direct side effects. In general, the effect of antibiotic residue in food of animal origin is significant when compared with the antibiotic misuse or selection and amplification of antibiotics resistant strain of bacteria (Peter and John, 2001).
Food animal origin such as meat, milk and eggs intended for human consumption, may have some residual amounts of veterinary drugs which remains in edible tissues after harvest. In some countries where legislative directions are followed by the farmer/producer, drug residue level will be within safe limits. In a relatively few cases, however, levels of residue exceed permitted maximum limits. This is attributed to the improper/ irrational drug use and as such, it is not legally allowed into the food system (WHO, 2000). Generally, there is no significant reported episodes of adverse human health effects occurring in food when the veterinary drugs were used at the correct dosages and at the levels permitted (FAO/OIE/WHO, 2003).
A wide spread availability and use of antimicrobials have several negative implications on global health care: among these developments of drug resistance is one. The primary economic implications of resistance on the diminishing efficacy of antibiotic treatment includes the need to rely on more expensive drugs that may be practically unaffordable for most primary health care programs (WHO, 2001). Antimicrobial residue remains very significant from the prospective of international trade and consumer confidence, because it results in international trade barrier. As tariffs are removed and goods flow freely between countries, importing countries must be in confident that goods available for purchase are safe, and in addition to this, from time to time, there is pressure to use antimicrobial residues on non-tariffs barrier to importation (Kanneene and Miller, 1997). Major economic loses and animal welfare problems could arise in veterinary medicine, because antimicrobial resistance has been found to cause therapy failure and higher mortality and morbidity rate (Acar, 1997; Kessar, 1997).
MEASURES TO PROMOTE RATIONAL VETERINARY DRUG USE
To avoid entering a post antibiotic era, agents around the world are determining the use and abuse of antimicro-bials (WHO, 2001). To reduce the risk of selecting resis-tant bacteria, the use of antibiotics must be restricted. Thus, the most attractive area for reducing the use of antibiotics is to ban their use as growth promoters. Some of the measures that reduce irrational (promote rational) drug use are as follows:
Herd health management
All food animals should be maintained in a clean healthy environment whenever possible. A nutritional program should in effect meet growth, maintenance and lactation needs. The veterinarian should implement a health program that encompasses preventive medical proce-dures. Drug misuse or irrationality are best avoided by implementing management practices and health programs that keeps animals healthy and producing efficiently (AVMA and NMPF, 1999; Radostitis, 1994).
Alternatives for antimicrobials growth promoters
Essentially, there are many ways by which we can reduce our dependence on antibiotic use in animals. Developing an alternative to antibiotics that work via similar mechanisms, promoting growth whilst enhancing the feed conversion efficiency, is the best option. A more difficult route would be to improve animal health.
Growth promoters have been shown to perform best when the condition is worst, that is when animal is in poor health and the living conditions are unhygienic; if their local environment is improved with overcrowded reduced and injection control technic is introduced, then the actual need for growth promoter may be removed (Prescott and Baggot, 1993).
Competitive exclusion products
These are in feed microbes consisting of a variety of spe-cies of bacteria that are marketed as being “friendly’’. The mechanism of action is believed to be that, by allowing bacteria to colonize the GIT, potential pathogens are pre-vented from colonizing the gut and thus causing infection. These products are often administered to new born ani-mals, especially poultry, to colonize the GIT and prevent Salmonella and Campylobacter infections. It is not known how the treatment is but it is believed to reduce diarrhea and level of mortality. These products are also given to animals that have been treated with therapeutic anti-biotics, to recolonize a gut that may be depopulated by antimicrobial action of the drug (Peter and John, 2001).
Probiotics are a term used for products containing “bene-ficial’’ microorganism. Most contain either Lactobacillus species (primarily L. acidophilus) or Streptococcus faccium. Additionally, they may contain vitamins, trace minerals and various growth factors (Haward, 1993). Probiotics are similar to exclusion products.
They are believed to improve the overall health of an animal by improving the microbial balance in its gut. It has been hypothesized that their action can be summarized in three ways. The first is reiteration of com-petitive exclusion principle by colonizing the gut in large number; the probiotic bacteria exclude pathogens and thus prevent them from causing infection. The second possibility is that they act as a stimulus for the immune system. As the immune system is engaged following ex-posure to probiotic bacteria; any hostile bacteria are also noticed. Following increased surveillance by leukocytes and thus potential pathogens are eliminated. The third suggestion proposes that probiotics have strong, positive influence on intestinal metabolic activities, such as increased production of vitamin B12, bacteriocins and propionic acid (Peter and John, 2001).
Prebiotics are defined as a non-digestible food ingredient that beneficially affects the host by selectively stimulating the growth and/or activity of one or a limited number of bacteria in the colon (Gibson and Roberfroid, 1995). In other words, prebiotics are meant to provide a substrate for beneficial GIT microbes. Large amounts of bacteria present in the mono-gastric small intestine and are potentially capable of utilizing these indigestible carbohy-drate sources for energy. Some researches (Hillman, 2001; Houdijk et al., 1997) have been conducted to manipulate beneficial bacteria in GIT. The use of prebiotics is promising approach for enhancing the role of endogenous beneficial organisms in the gut as suggested by Bezkorovainy (2001). They can be used as potential alternatives to growth promoting antibiotics (Hatemink, 1995). The use of prebiotics or fermentable sugars instead of antibiotics is going to be popular in birds in order to improve the useful microbial population of the GIT (Kermanshahi and Rostami, 2006).
IN FEED ENZYMES
Enzymes are routinely added to animal feeds and work by helping to break down certain components of the feed that the animal may have problems in digesting. They are produced by fermentation processes from fungi and bacteria and seen to only have a positive effect on the animal. The scientific committee for animal nutrition concludes that conditions of use evaluated so far are acceptable as respected to consumers, users and animals (Peter and John, 2001).
INFECTIOUS CONTROL MECHANISM
The use of antimicrobial as growth promoting agent rests on their role in controlling infection in growing animals. Similarly, many of the alternatives are aimed at controlling infection, often indirectly. For instance, the Australian pig farming pioneered the ‘’all in-all out’’ method of pig production. This is a new system used to replace the older technique of having constant system of pig moving through the farm. Instead of having a range of ages, all the pigs weaned within a week are designated into a single cohort and are housed together in one shed. They are not allowed to mix with pigs from other cohort and so cross infection between groups are prevented. The “Specific Pathogen Free’’ system is used to prevent pigs from acquiring many of the disease that require antibiotic intervention. To achieve this they are born by hysterectomy and hand reared. This will only be cost effective for valuable breeding stock. Finally, vaccination is used to offer protection against certain pathogens, such as enterotoxigenic E.coli and various Mycoplasma infections (Peter and John, 2001).
ADHERING TO WITHDRAWAL PERIOD
The withdrawal time (also known as the depletion or clearance period) is the time for the residue of toxicological concern to reach safe concentration as defined by the tolerance. Depending on the drug product, dosage form, and route of administration, the withdrawal time may vary from a few hours to several days or weeks. It is the interval necessary between the last administra-tion to the animals of the drug under normal condition of use and the time when treated animal can be slaughtered or the production of safe foodstuffs (Kanneene and Miller, 1997). To ensure that drug residues have declined to a safe concentration following the use of drugs in animals, a specified period of drug withdrawal must be observed prior to providing any products for human consumption. Drug withdrawal time is the time required for drug resi-dues to reach a safe concentration for human or animal consumption, and defined as maximum residual limit (MRL). Failure to follow recommended withdrawal time is often implicated in residual problems (GOV.UK, 2013). It is advisable to follow recommended withdrawal time to avoid residual effects of drugs in the food of animal origin; that is, we have to check and observe the with-drawal period laid down for the particular medicine and food animals should not be sold for slaughter, or slaugh-tered before the end of withdrawal period (Gracey, 1999).
MINIMIZING MISUSE OF ANTIMICROBIAL
This is achieved by different strategies. These are: educations of prescribers and dispensers (including drug sellers); education of the farmers to create awareness; limiting the availability of antimicrobials to prescription; ensuring that only antimicrobials meeting international standards of quality, safety and efficiency are granted marketing authorization; establishing and maintaining up-dated national standard treatment guidelines; developing guidelines for veterinarians to reduce overuse and misuse of antimicrobial in food animals and enhancing immunization coverage and other preventive measures, thereby reducing the need for antimicrobial (Gracey, 1999). WHO came out with twelve core interventions to promote more rational use of medicines. Some of them are: public education about medicines; clinical guidelines; appropriate and enforced regulations; supervision, audit and feedback; independent information on medicines and problem based pharmacotherapy training in undergraduate curriculum (WHO, 2004).
Although veterinary drugs have played a great role in control and prevention of disease in animals, and promote the growth of food animals , its use is associated with problems such as development of resistance and residual effects in food animals. These adverse effects are generally due to irrational use of drugs such as misuse, extensive use, failure to keep strict adherence of withdrawal and withholding time of drugs. The develop-ment of resistant micro-organisms in animal and the presence of drug residue in food of animal origin have significant effect on public health.
Therefore, strict control measures to promote rational veterinary drug use have crucial importance on global enconomy and public health.
E. coli, Escherichia coli; FAO, Food and Agriculture Organization; GIT, gastro-intestinal tract; GP, growth promoter; IDU, irrational drug use; JECFA, Joint FAO/WHO Expert Committee on Food Additives; MRL, maximum residue level; NAS, National Academic Sciences; OIE, Office International des Epizooties; RDU, Rational drug Use; Vet, veterinary; Vet. Med, veterinary medicine; WHO, World Health Organization; WP, withdrawal period.
Acar JF (1997). Consequences of bacterial resistance to antibiotics in medical practice. Clin. Infect. Dis. 24:17-18.
|American Veterinary Medical Association (AVMA) and National Milk Producers Federation (NMPA) (1999). Milk and beef residue prevention: a quality assurance protocol. J. Am. Vet. Med. Assoc. 64:1-24.|
|Bezkorovainy A (2001). Probiotics: Determinants of survival and growth in the gut. Am. J. Clin. Nutr. 73:3995-4055.|
|Brahma D, Marak M, Wahlang J (2012). Rational Use of Drugs and Irrational Drug Combinations. Internet J. Pharmacol. 10 (1).|
|Catery B, Laevens H, Deverisa LA, Opsomer G De Kruif A (2003). Antimicrobial resistance in milk and meat; Perceptions and realities. J. Vet. Med. 87:1222-1228.|
|FAO (1984). Residues of veterinary drugs in foods: Report of a joint FAO/WHO Expert consultation, Food and Agricultural Organization, Rome, Italy. pp. 1-16.|
|FAO/OIE/WHO (2003). Expert workshop on non-human antimicrobial resistance: scientific assessment. Geneva, Switzerland. pp. 19-20.|
|Fingleton J (2004). Legislation for veterinary drugs control. FAO Legal papers online#38. Pp. 1-26.|
|Gibson GR, Roberfroid MB (1995). Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J Nutr.125:223-229.|
|Gracey JF, Collins DS, Hvey RJ (1999).Meat hygiene, 10th edition. Harcourt Brace Press, London. pp. 299-319.|
Graham JP, Boland JJ, Silbergeld E (2007). Growth Promoting Antibiotics in Food Animal Production: An Economic Analysis. Public Health Rep. 122(1):79-87.
Grandle A, Sri-Ngernyuang L, Streefland PH (1993). Enhancing appropriate drug use: the promotion of herbal medicine promotion. Soc. Sci. Med. 36:1023-1035.
|GOV.UK (2013). Guidance Veterinary medicines for livestock. Livestock and Food and farming, Department for Environment, Food & Rural Affairs.|
|Hatemink R (1995). Non digestible oligosaccharides: Healthy food for the colon. J Vet. Med. 56:21-22.|
|Haward AJ (1993). Current Veterinary Therapy, 3rd edition. WB Saunders Company Press, Mexico. pp. 29-38.|
|Hillman K (2001). Bacteriological aspects of the use of antibiotics and their alternatives in the feed of non-ruminant animals. In: Worthy GP, Wiseman J (eds.), Recent Advances in Animal Nutrition. Nottingham University Press, Nottingham. pp. 107-134.|
|Hirsh DC, Zee YC (1999). Veterinary microbiology, 1st ed. Blackwell Publishing Company, California. pp. 48-57.|
|Houdijk JG, Williams BA, Tamming S, Verstegen MW (1997). Relation between in vivo and in vitro fermentation of oligosaccharides in weaner pigs. Proc. Brit. Soc. Anim. Sci. 59:170-175.|
|Jensen BB (1998). The impact of feed additives on the microbial eco-logy of the gut in the young pigs. J. Am. Vet. Med. Assoc. 7:45-46.|
|Kanneene JB, Miller R (1997). Problems associated with drug residues in beef from feeds and therapy. Rev. Sci. Technol. 16:694-708.|
Kermanshahi H, Rostami H (2006). Influence of supplemental dried whey on broiler performance and cecal flora. Int. J. Poult. Sci. 5:538-543.
Kessar RE (1997). Prospective on chemotherapeutic approaches to antibiotic resistant bacteria. Clin. Infect. Dis. 24:146-147.
|NAS (National Academy of Sciences) (1999). The use of drugs in food animals: Benefits and risks. National academy press, Washington, D.C. pp. 4-11.|
|Peter H, John H (2001). Antibiotics growth promoter. J. Vet. Pharmacol. Therap. 24:5-13.|
|Prescott JF, Baggot JD (1993). Antimicrobial therapy in Veterinary Medicine, 2nd ed. Iowa State University Press, Amsterdam. pp. 564-565.|
|Radostitis OM (1994). Residue testing and avoidance. Herd Health: Food Animal Production Medicine. Saunders Company, Philadelphia. pp. 59-66.|
|Shivhare SC, Kunjwani HK, Manikrao AM, Bondre AV (2010). Drugs hazards and rational use of drugs. J. Chem. Pharm. Res. 2:106-112.|
|Stobberingh EE, Van den Bogaard AE (2000). Spread of antibiotic resistance from food of animals to man. Acta. Vet. Scand. 93:47-52.|
Thawani V (2010). Rational use of medicines: Achievements and challenges. Indian J. Pharmacol. 42:63-4.
|Vitomir C, Silva D, Biljana A, Sanja C (2011). The significance of rational use of drugs in veterinary medicine for food safety. Technol. Mesa 52 (1):74-79.|
|WHO (2000). World Health Organization Global principles for the containment of antimicrobial resistance in animals intended for food. Report of WHO Consultation with the participation of the FAO and OIE in Switzerland, Geneva.|
|WHO (2001). Monitoring antimicrobial usage in food animals for the protection of human health. Reports of a WHO Consultation, Oslo, Norway.|
|WHO (2002). WHO policy perspectives on medicine promoting rational use of medicines. Available from: WHO Model Formulary. Geneva: WHO Press.|
|WHO (2004). World Health Organization Model Formulary, WHO press, Geneva, Switzerland. [http://www.apps.who.int/trs/who_trs_eng.pdf]WHO (1988). Joint FAO/WHO Expert Committee on Feed Additives (JECFA) (2006). Toxicological evaluation of certain veterinary drug residues in food: monograph prepared by the 32nd meeting of the joint FAO/WHO Expert Committee on Food Additives|
Copyright © 2022 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0